Company / FCF Margin
Eloxx Pharmaceuticals, Inc. FCF Margin History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-2673.2%
FY2016
5-year range
-56151.8% / -2673.2%
FY2014-FY2016
Trend
+94.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -56151.8% to -2673.2% over the past 2 years.
Based on SEC 10-K filings.
-2673.2% in FY2016.
Improved from -56151.8% to -2673.2% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, fcf margin increased 94.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2016 | -2673.2% | +94.6% |
| FY2015 | -49928.5% | +11.1% |
| FY2014 | -56151.8% | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026